Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse

Journal of Leukocyte Biology

Volumn 83, Issue 5, 2008, Pages 1194-1200

  Wildenberg, Manon E ^a   Van Helden Meeuwsen, Cornelia G ^a   Van De Merwe, Joop P ^a   Moreno, Christophe ^b   Drexhage, Hemmo A ^a   Versnel, Marjan A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Autoimmunity; Chemokine receptor; Regulation; Sj gren's syndrome

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; INTERLEUKIN 12; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SALIVARY GLAND; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD11C; DENDRITIC CELLS; HUMANS; INFLAMMATION; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MIDDLE AGED; RECEPTORS, CCR5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SALIVARY GLANDS; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND;

ANIMALIA;

EID: 46949086975     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107794     Document Type: Article

References (55)

1. Hu, Y., Nakagawa, Y., Purushotham, K. R., Humphreys-Beher, M. G. (1992) Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263, E607-E614.
2. van Blokland, S. C., van Helden-Meeuwsen, C. G., Wierenga-Wolf, A. F., Drexhage, H. A., Hooijkaas, H., van de Merwe, J. P., Versnel, M. A. (2000) Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjogren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? Lab. Invest. 80, 575-585.
3. Shortman, K., Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
4. Dubois, B., Bridon, J. M., Fayette, J., Barthelemy, C., Banchereau, J., Caux, C., Briere, F. (1999) Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol. 66, 224-230.
5. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., Palucka, A. K., Banchereau, J. (2007) Dendritic cell subsets in health and disease. Immunol. Rev. 219, 118-142.
6. Steinman, R. M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
7. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S., Caux, C. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386.
8. Weis, M., Schlichting, C. L., Engleman, E. G., Cooke, J. P. (2002) Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler. Thromb. Vasc. Biol. 22, 1817-1823.
9. Zlotnik, A., Yoshie, O., Nomiyama, H. (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7, 243.
10. Murdoch, C., Finn, A. (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032-3043.
11. Patel, L., Charlton, S. J., Chambers, J. K., Macphee, C. H. (2001) Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine 14, 27-36.
12. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., Lanzavecchia, A. (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
13. Vecchi, A., Massimiliano, L., Ramponi, S., Luini, W., Bernasconi, S., Bonecchi, R., Allavena, P., Parmentier, M., Mantovani, A., Sozzani, S. (1999) Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J. Leukoc. Biol. 66, 489-494.
14. Yanagawa, Y., Onoe, K. (2003) CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 101, 4923-4929.
15. Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., Littman, D. R., Reinecker, H. C. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258.
16. Flanagan, K., Moroziewicz, D., Kwak, H., Horig, H., Kaufman, H. L. (2004) The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell. Immunol. 231, 75-84.
17. Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., Pustilnik, T., Curiel, D. T., Galanaud, P., Capron, F., Emilie, D., Curiel, T. J. (2001) Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7, 1339-1346.
18. Marsland, B. J., Battig, P., Bauer, M., Ruedl, C., Lassing, U., Beerli, R. R., Dietmeier, K., Ivanova, L., Pfister, T., Vogt, L., Nakano, H., Nembrini, C., Saudan, P., Kopf, M., Bachmann, M. F. (2005) CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22, 493-505.
19. Dawson, T. C., Beck, M. A., Kuziel, W. A., Henderson, F., Maeda, N. (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156, 1951-1959.
20. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., Pillemer, S. R., Talal, N., Weisman, M. H. (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554-558.
21. Mueller, A., Strange, P. G. (2004) Mechanisms of internalization and recycling of the chemokine receptor, CCR5. Eur. J. Biochem. 271, 243-252.
22. DePaolo, R. W., Lathan, R., Karpus, W. J. (2004) CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT. J. Immunol. 173, 314-320.
23. Proudfoot, A. E., Power, C. A., Hoogewerf, A. J., Montjovent, M. O., Borlat, F., Offord, R. E., Wells, T. N. (1996) Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271, 2599-2603.
24. Bouma, G., Nikolic, T., Coppens, J. M., van Helden-Meeuwsen, C. G., Leenen, P. J., Drexhage, H. A., Sozzani, S., Versnel, M. A. (2005) NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur. J. Immunol. 35, 225-235.
25. Zhou, Y., Kurihara, T., Ryseck, R. P., Yang, Y., Ryan, C., Loy, J., Warr, G., Bravo, R. (1998) Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160, 4018-4025.
26. Algood, H. M., Flynn, J. L. (2004) CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173, 3287-3296.
27. Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T., Kuziel, W. A., Maeda, N., MacDermott, R. P., Podolsky, D. K., Reinecker, H. C. (2000) Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164, 6303-6312.
28. Moreno, C., Nicaise, C., Gustot, T., Quertinmont, E., Nagy, N., Parmentier, M., Louis, H., Deviere, J. (2006) Chemokine receptor CCR5 deficiency exacerbates caerulein-induced acute pancreatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G1089-G1099.
29. Ariel, A., Fredman, G., Sun, Y. P., Kantarci, A., Van Dyke, T. E., Luster, A. D., Serhan, C. N. (2006) Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 7, 1209-1216.
30. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., Mantovani, A. (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1, 387-391.
31. Poligone, B., Weaver Jr., D. J., Sen, P., Baldwin Jr., A. S., Tisch, R. (2002) Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168, 188-196.
32. Alleva, D. G., Pavlovich, R. P., Grant, C., Kaser, S. B., Beller, D. I. (2000) Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49, 1106-1115.
33. Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal Malefyt, R., Kastelein, R. A., Cua, D. J. (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96-105.
34. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., Adorini, L. (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181, 817-821.
35. Trembleau, S., Penna, G., Gregori, S., Gately, M. K., Adorini, L. (1997) Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27, 2330-2339.
36. Kolkowski, E. C., Reth, P., Pelusa, F., Bosch, J., Pujol-Borrell, R., Coll, J., Jaraquemada, D. (1999) Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjogren's syndrome. J. Autoimmun. 13, 155-162.
37. McGrath-Morrow, S., Laube, B., Tzou, S. C., Cho, C., Cleary, J., Kimura, H., Rose, N. R., Caturegli, P. (2006) IL-12 overexpression in mice as a model for Sjogren lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L837-L846.
38. Amano, H., Bickerstaff, A., Orosz, C. G., Novick, A. C., Toma, H., Fairchild, R. L. (2005) Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J. Immunol. 174, 6499-6508.
39. Nozaki, T., Amano, H., Bickerstaff, A., Orosz, C. G., Novick, A. C., Tanabe, K., Fairchild, R. L. (2007) Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J. Immunol. 179, 5238-5245.
40. Harley, J. B., Alexander, E. L., Bias, W. B., Fox, O. F., Provost, T. T., Reichlin, M., Yamagata, H., Arnett, F. C. (1986) Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum. 29, 196-206.
41. Watanabe, T., Tsuchida, T., Kanda, N., Mori, K., Hayashi, Y., Tamaki, K. (1999) Anti-α-fodrin antibodies in Sjogren syndrome and lupus erythematosus. Arch. Dermatol. 135, 535-539.
42. Yanagi, K., Ishimaru, N., Haneji, N., Saegusa, K., Saito, I., Hayashi, Y. (1998) Anti-120-kDa α-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjogren's syndrome. Eur. J. Immunol. 28, 3336-3345.
43. Gao, J., Killedar, S., Cornelius, J. G., Nguyen, C., Cha, S., Peck, A. B. (2006) Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J. Autoimmun. 26, 90-103.
44. Kelso, A. (1995) Th1 and Th2 subsets: paradigms lost? Immunol. Today 16, 374-379.
45. Fitzpatrick, D. R., Kelso, A. (1998) Independent regulation of cytokine genes in T cells: the paradox in the paradigm. Transplantation 65, 1-5.
46. Mitsias, D. I., Tzioufas, A. G., Veiopoulou, C., Zintzaras, E., Tassios, I. K., Kogopoulou, O., Moutsopoulos, H. M., Thyphronitis, G. (2002) The Th1/ Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin. Exp. Immunol. 128, 562-568.
47. Araujo, L. M., Lefort, J., Nahori, M. A., Diem, S., Zhu, R., Dy, M., Leite-de-Moraes, M. C., Bach, J. F., Vargaftig, B. B., Herbelin, A. (2004) Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur. J. Immunol. 34, 327-335.
48. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., Parmentier, M. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
49. Mummidi, S., Bamshad, M., Ahuja, S. S., Gonzalez, E., Feuillet, P. M., Begum, K., Galvis, M. C., Kostecki, V., Valente, A. J., Murthy, K. K., Haro, L., Dolan, M. J., Allan, J. S., Ahuja, S. K. (2000) Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J. Biol. Chem. 275, 18946-18961.
50. Gambelunghe, G., Ghaderi, M., Brozzetti, A., Del Sindaco, P., Gharizadeh, B., Nyren, P., Hjelmstrom, P., Nikitina-Zake, L., Sanjeevi, C. B., Falorni, A. (2003) Lack of association of CCR2-64I and CCR5-Δ 32 with type 1 diabetes and latent autoimmune diabetes in adults. Hum. Immunol. 64, 629-632.
51. Dubois-Laforgue, D., Hendel, H., Caillat-Zucman, S., Zagury, J. F., Winkler, C., Boitard, C., Timsit, J. (2001) A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50, 1211-1213.
52. Aguilar, F., Nunez-Roldan, A., Torres, B., Wichmann, I., Sanchez-Roman, J., Gonzalez-Escribano, M. F. (2003) Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30, 1770-1774.
53. Mlynarski, W. M., Placha, G. P., Wolkow, P. P., Bochenski, J. P., Warram, J. H., Krolewski, A. S. (2005) Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes 54, 3331-3335.
54. Yang, B., Houlberg, K., Millward, A., Demaine, A. (2004) Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 26, 114-121.
55. Petrek, M., Cermakova, Z., Hutyrova, B., Micekova, D., Drabek, J., Rovensky, J., Bosak, V. (2002) CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin. Exp. Rheumatol. 20, 701-703.